Tebuconazole exposure disrupts placental function and causes fetal low birth weight in rats. (February 2021)

• Record Type: Journal Article
• Authors: Ying, Yingfen; Pan, Peipei; Zou, Cheng; Wang, Yiyan; Tang, Yunbing; Hou, Xiaohong; Li, Yang; Xu, Qiang; Lin, Liben; Lu, Jieqiang; Ge, Ren-shan
• Is Part Of: Chemosphere. Volume 264(2021)Part 2
• Publication Date: 2021-02
• Subjects: Tebuconazole -- Low birth weight -- Placental dysfunction -- Trophoblast -- Fertilization -- Estradiol; Pollution -- Periodicals; Pollution -- Physiological effect -- Periodicals; Environmental sciences -- Periodicals; Atmospheric chemistry -- Periodicals; 551.511
• DOI: 10.1016/j.chemosphere.2020.128432
• Languages: English
• ISSNs: 0045-6535

Abstract

Abstract: Tebuconazole (TEB) is one of the widely used broad-spectrum triazole fungicides. Its accumulation in mammals leads to various endocrine disruptions. However, it is unclear whether the exposure of TEB during pregnancy affects the growth and development of fetus and placenta. Here, TEB was exposed to pregnant Sprague-Dawley female rats from gestational days 12–21 of 0, 25, 50 or 100 mg/kg for 10 days. TEB reduced placental estradiol levels. TEB disrupted the structure and function of the placenta, leading to hypertrophy, fibrin exudation, edema, calcification, arterial fibroblast proliferation, and trophoblastic infarction. RNA-seq analysis showed that TEB mainly down-regulated the expression of iron transport genes and up-regulated the expression of genes for immune/inflammatory responses. Further qPCR showed that TEB down-regulated Tfrc, Hamp, Eif2ak2 and up-regulated the expression of Cd34, Cd36, Jag1, Pln, Cyp1a1, Esrra, and Aqp1 at 50 and 100 mg/kg. Western blot and semi-quantitative immunohistochemical staining also demonstrated that TEB lowered the levels of TFRC and EIF2AK2 and increased the levels of CD34, CD36, JAG1, CYP1A1, and ESRRA at 50 and 100 mg/kg. In conclusion, TEB severely damages the structure and function of the placenta, leading to hypertrophy of the placenta, low birth weight and feminization of the male fetus possibly via several pathways including iron transport and TNF signaling. Graphical abstract: Image 1 Highlights: Tebuconazole damages the structure and function of the placenta. Tebuconazole causes pathological changes of the placenta. Tebuconazole down-regulated Tfrc and Eif2ak2 expression. Tebuconazole up-regulated the expression of Cd34, Cd36, Jag1, Cyp1a1, Esrra. Tebuconazole lowers placental estradiol level.